Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glass House Brands is a publicly traded, vertically integrated cannabis company focused primarily on the California market. The company cultivates cannabis at scale using greenhouse operations, manufactures cannabis products, owns and manages consumer brands, and operates retail dispensaries. Its portfolio includes flower, pre-rolls, gummies, and topical wellness products sold under brands such as Glass House Farms, PLUS, Allswell, Forbidden Flowers, FIELD, and Mama Sue Wellness. Glass House positions itself around sustainable large-scale cultivation, low-cost production, and brand-led commercialization rather than traditional biopharmaceutical drug development. For a biotech or healthcare-oriented analyst, it is best understood as a commercial cannabis consumer packaged goods and retail platform, not a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glass House Brands.